[go: up one dir, main page]

PT1000086E - ALATROFLOXACIN PARENTER COMPOSITIONS - Google Patents

ALATROFLOXACIN PARENTER COMPOSITIONS

Info

Publication number
PT1000086E
PT1000086E PT98932444T PT98932444T PT1000086E PT 1000086 E PT1000086 E PT 1000086E PT 98932444 T PT98932444 T PT 98932444T PT 98932444 T PT98932444 T PT 98932444T PT 1000086 E PT1000086 E PT 1000086E
Authority
PT
Portugal
Prior art keywords
parenter
alatrofloxacin
compositions
parenter compositions
alatrofloxacin parenter
Prior art date
Application number
PT98932444T
Other languages
Portuguese (pt)
Inventor
Subramanian Sam Guhan
Stanley Walter Walinsky
Robert Mark Guinn
John Francis Lambert
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PT1000086E publication Critical patent/PT1000086E/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT98932444T 1997-08-01 1998-07-23 ALATROFLOXACIN PARENTER COMPOSITIONS PT1000086E (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5424697P 1997-08-01 1997-08-01

Publications (1)

Publication Number Publication Date
PT1000086E true PT1000086E (en) 2004-05-31

Family

ID=21989735

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98932444T PT1000086E (en) 1997-08-01 1998-07-23 ALATROFLOXACIN PARENTER COMPOSITIONS

Country Status (40)

Country Link
US (1) US6194429B1 (en)
EP (1) EP1000086B1 (en)
JP (1) JP3463928B2 (en)
KR (1) KR20010022495A (en)
CN (1) CN1265671A (en)
AP (1) AP1031A (en)
AR (1) AR015417A1 (en)
AT (1) ATE259827T1 (en)
AU (1) AU734863B2 (en)
BG (1) BG104105A (en)
BR (1) BR9811580A (en)
CA (1) CA2296466C (en)
CO (1) CO4970688A1 (en)
DE (1) DE69821767T2 (en)
DK (1) DK1000086T3 (en)
DZ (1) DZ2576A1 (en)
EA (1) EA002120B1 (en)
ES (1) ES2214716T3 (en)
GT (1) GT199800112A (en)
HN (1) HN1998000106A (en)
HR (1) HRP980417B1 (en)
HU (1) HUP0004793A3 (en)
ID (1) ID24374A (en)
IL (1) IL134156A0 (en)
IS (1) IS5339A (en)
MA (1) MA24626A1 (en)
NO (1) NO20000485L (en)
NZ (1) NZ502249A (en)
OA (1) OA11281A (en)
PA (1) PA8456701A1 (en)
PE (1) PE103799A1 (en)
PL (1) PL338477A1 (en)
PT (1) PT1000086E (en)
SK (1) SK1012000A3 (en)
TN (1) TNSN98146A1 (en)
TW (1) TW538043B (en)
UY (1) UY25113A1 (en)
WO (1) WO1999006430A1 (en)
YU (1) YU2500A (en)
ZA (1) ZA986874B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20010635A1 (en) * 1999-10-08 2001-08-15 Smithkline Beecham Corp USEFUL FAB I INHIBITORS FOR THE TREATMENT OF BACTERIAL INFECTIONS
EP1121933A1 (en) * 2000-02-02 2001-08-08 Pfizer Products Inc. Premixed alatrofloxacin injectable compositions
DK1560584T3 (en) 2001-04-06 2009-05-18 Affinium Pharm Inc Fab I inhibitors
DK1575951T3 (en) * 2002-12-06 2014-09-15 Debiopharm Int Sa HETEROCYCLIC COMPOUNDS, METHODS OF PRODUCING THEREOF AND THEIR USE IN THERAPY
CA2519429C (en) 2003-03-17 2013-08-06 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
CA2467321A1 (en) * 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
KR101299399B1 (en) 2004-06-04 2013-08-22 아피늄 파마슈티컬스, 인크. Therapeutic Agents, and Methods of Making and Using the Same
US20090156578A1 (en) * 2005-12-05 2009-06-18 PAULS Henry 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
WO2008009122A1 (en) 2006-07-20 2008-01-24 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab i inhibitors
EP2125802A4 (en) * 2007-02-16 2014-08-20 Debiopharm Int Sa Salts, prodrugs and polymorphs of fab i inhibitors
BR122021020778B1 (en) 2012-06-19 2022-07-12 Debiopharm International Sa PRO-Drug DERIVATIVES OF (E)-N-METHYL-N-((3-METHYLBENZOFURAN-2-YL) METHYL)-3-(7-OXO-5,6,7,8-TETRAHYDRO-1,8- NAFTIRINDIN-3-IL) ACRYLAMIDE
RU2716164C2 (en) * 2014-04-25 2020-03-06 Наурекс, Инк. Stable compositions of neuroactive peptides
SI3419628T1 (en) 2016-02-26 2021-03-31 Debiopharm International Sa Medicament for treatment of diabetic foot infections
WO2019148294A1 (en) 2018-02-02 2019-08-08 Interface Biologics, Inc. Dimeric dexamethasone prodrug compositions and uses thereof
CN113661170B (en) 2019-02-01 2025-04-15 波纹疗法公司 Crystalline form of dexamethasone dimer and its use
PH12021551922A1 (en) 2019-02-14 2022-05-23 Debiopharm Int Sa Afabicin formulation, method for making the same
UA129222C2 (en) 2019-06-14 2025-02-12 Дебіофарм Інтернешнл С.А. Afabicin for use for treating bacterial infections involving biofilm
WO2021024039A1 (en) 2019-08-07 2021-02-11 Ripple Therapeutics Corporation Compositions and methods for the treatment of pain and dependance disorders
WO2021220061A2 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3713672A1 (en) 1987-04-24 1988-11-17 Bayer Ag METHOD FOR PRODUCING PARENTERALLY AVAILABLE CHINOLONIC CARBONIC ACIDS
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5256791A (en) 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
CZ286896B6 (en) 1994-01-18 2000-07-12 Pfizer Process for preparing pharmaceutically acceptable salts of naphthyridone carboxylic acid and intermediates for this preparation
TW420610B (en) 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5475116A (en) 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
JP3145715B2 (en) 1995-06-06 2001-03-12 ファイザー・インコーポレーテッド Anhydrous 7-([1α, 5α, 6α] -6-amino-3-azabicyclo [3.1.0] hex-3-yl) -6-fluoro-1- (2,4-difluorophenyl) -1, Novel crystalline form of 4-dihydro-4-oxo-1,8-naphthyridin-3-carboxylic acid methanesulfonate
DK0833837T3 (en) * 1995-06-15 2002-09-02 Pfizer Process for the preparation of derivatives of azabicyclonaphthydridine carboxylic acid comprising a dipeptide
CA2230303C (en) * 1995-08-29 2001-07-24 Douglas J. M. Allen Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin
CA2229786C (en) 1995-08-29 2002-02-19 David Bruning Joseph Zwitterionic forms of trovafloxacin
GB9524466D0 (en) 1995-11-30 1996-01-31 Pfizer Ltd Process
JPH1087617A (en) 1996-07-09 1998-04-07 Pfizer Inc Preparation of intermediates useful for the synthesis of quinoline antibiotics

Also Published As

Publication number Publication date
SK1012000A3 (en) 2000-09-12
CA2296466A1 (en) 1999-02-11
DZ2576A1 (en) 2003-02-22
CN1265671A (en) 2000-09-06
EA200000086A1 (en) 2000-08-28
ID24374A (en) 2000-07-13
AU734863B2 (en) 2001-06-21
NO20000485L (en) 2000-03-27
YU2500A (en) 2002-09-19
PA8456701A1 (en) 2000-05-24
PE103799A1 (en) 1999-10-25
PL338477A1 (en) 2000-11-06
AP1031A (en) 2001-12-21
BR9811580A (en) 2000-08-22
AU8236898A (en) 1999-02-22
IL134156A0 (en) 2001-04-30
JP2001512133A (en) 2001-08-21
JP3463928B2 (en) 2003-11-05
DK1000086T3 (en) 2004-05-17
US6194429B1 (en) 2001-02-27
ES2214716T3 (en) 2004-09-16
OA11281A (en) 2002-11-19
NZ502249A (en) 2001-11-30
UY25113A1 (en) 2000-12-29
MA24626A1 (en) 1999-04-01
ATE259827T1 (en) 2004-03-15
TNSN98146A1 (en) 2005-03-15
BG104105A (en) 2000-08-31
CA2296466C (en) 2003-04-15
EP1000086A1 (en) 2000-05-17
IS5339A (en) 2000-01-14
TW538043B (en) 2003-06-21
HUP0004793A3 (en) 2001-10-29
AP9801310A0 (en) 1998-09-30
KR20010022495A (en) 2001-03-15
DE69821767D1 (en) 2004-03-25
GT199800112A (en) 2000-01-15
CO4970688A1 (en) 2000-11-07
HUP0004793A2 (en) 2001-04-28
AR015417A1 (en) 2001-05-02
ZA986874B (en) 2000-01-31
NO20000485D0 (en) 2000-01-31
EP1000086B1 (en) 2004-02-18
HRP980417B1 (en) 2002-10-31
WO1999006430A1 (en) 1999-02-11
HN1998000106A (en) 1999-01-08
DE69821767T2 (en) 2005-01-13
HRP980417A2 (en) 1999-08-31
EA002120B1 (en) 2001-12-24

Similar Documents

Publication Publication Date Title
ID22931A (en) HERBISIDAL COMPOSITIONS
DK1298194T3 (en) Staniol-containing compositions
FI974241L (en) BPM-15 compositions
MX208461B (en) THERMOFRAGUATED POLYSACARIDS
DE69718508D1 (en) ANTITRASPIRANT COMPOSITION
ID16251A (en) KUMAN EXTENSION COMPOSITIONS
DE69832516D1 (en) ISOFLAVON CONTAINING COMPOSITIONS
ID25508A (en) DEMATOLOGICAL COMPOSITION
ATE209959T1 (en) MICRO-ENCAPSULED COMPOSITIONS
BR9606809A (en) Insecticide-active composition
DE69733072D1 (en) COLOR-EFFECTIVE COMPOSITIONS
PT1000086E (en) ALATROFLOXACIN PARENTER COMPOSITIONS
BR9607058A (en) Composition
DE69617029D1 (en) ORGANOTON COMPOSITIONS
NO981568D0 (en) Randtennings-priming compositions
DE69719442D1 (en) Frisierschaum compositions
ID19589A (en) COMPOSITION
NO984662L (en) Water-in-oil emulsjonsgj ° dningsstoff compositions
ID25650A (en) SAMPO COMPOSITIONS
ID23250A (en) PAROXSETIN COMPOSITION
ID21906A (en) ADESIVE COMPOSITION
DE69822559D1 (en) silicone composition
BR9707835A (en) Composition
DE69826706D1 (en) WÄSCHEWEICH COMPOSITIONS
DE69603228D1 (en) Aluminoxanate compositions